Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
03/05/2003 | CN1400505A Image forming material and ammonium compound |
03/04/2003 | US6528530 Side effect reduction; mainly the D-threo stereoisomer of a phenidate |
03/04/2003 | US6528529 Compounds with activity on muscarinic receptors |
03/04/2003 | CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
02/28/2003 | CA2399567A1 Crystalline material |
02/27/2003 | WO2003016278A1 Process for preparation of piperidin-2-ylacetic acid |
02/27/2003 | WO2003016274A2 2-substituted piperidines that are ligands for monoamine receptors and transporters |
02/27/2003 | WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
02/27/2003 | WO2002102777A3 NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE |
02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
02/27/2003 | WO2002083641A3 Amino-aza-cyclohexanes for the treatment of malaria |
02/27/2003 | WO2002079149A3 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
02/27/2003 | WO2002074050A3 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
02/27/2003 | WO2002067869A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
02/27/2003 | WO2002060388A3 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
02/27/2003 | WO2002046157A3 Methods for the stereoselective synthesis of substituted piperidines |
02/27/2003 | WO2002017919A3 Use of threo-methylphenidate compounds to enhance memory |
02/27/2003 | US20030040532 Methods for treating dementia due to HIV disease |
02/27/2003 | US20030040530 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containning them |
02/26/2003 | EP1285917A1 Process for producing carbostyril derivative |
02/26/2003 | EP1285655A1 Stabilized pharmaceutical compositions containing calcium channel blockers |
02/26/2003 | EP1284966A2 Process for the synthesis of amine ethers from secondary amino oxides |
02/26/2003 | EP1284961A1 Glycinamides |
02/26/2003 | EP1284954A1 Method for the production of esters of unsaturated carboxylic acids |
02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
02/26/2003 | EP1042297B1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
02/26/2003 | EP0938483B1 Muscarinic antagonists |
02/26/2003 | EP0798295B1 Novel amidinonaphthyl derivative or salt thereof |
02/26/2003 | CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
02/25/2003 | US6525215 HIV protease inhibitors |
02/25/2003 | US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
02/25/2003 | US6525199 Ring coupling, reduction and deprotecting; synthesis of compounds for alleviation and treatment of symptoms due to ischemic diseases |
02/25/2003 | US6525077 Cyanoguanidine prodrugs |
02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
02/25/2003 | US6525069 Such as N-(t-butyl)-N'-(2-((3-(4-fluorophenyl)methyl)piperi -dinyl)methyl)cyclohexyl)urea; prevention of asthma and other allergic diseases |
02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
02/25/2003 | US6525042 Sulfonyl derivatives |
02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
02/25/2003 | US6525020 For drug delivery |
02/20/2003 | WO2003014085A1 Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
02/20/2003 | WO2003014084A1 Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation |
02/20/2003 | WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
02/20/2003 | WO2003013531A1 Phenyl derivatives as factor xa inhibitors |
02/20/2003 | WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
02/20/2003 | WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors |
02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
02/20/2003 | WO2002100829A3 Process for the preparation of paroxetine substantially free of alkoxy impurities |
02/20/2003 | WO2002068387A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
02/20/2003 | US20030036659 Method for the production of n-alkenyl amides |
02/20/2003 | US20030036654 Useful as mediators of protein-protein interactions |
02/20/2003 | US20030036553 Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis |
02/20/2003 | US20030036552 Novel compounds |
02/20/2003 | DE20217957U1 Oxidative dyeing agent for keratin fibers uses 2-aminomethylene-substituted resorcinols as couplers, some of which are novel compounds |
02/20/2003 | CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
02/20/2003 | CA2455861A1 Sulfonamide derivatives as gamma secretase inhibitors |
02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
02/19/2003 | EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof |
02/19/2003 | EP0979818B1 Benzoic acid compounds and medicinal use thereof |
02/19/2003 | EP0863752B1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
02/19/2003 | CN1398252A Dehydroamino acids compounds |
02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
02/19/2003 | CN1397550A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
02/19/2003 | CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
02/19/2003 | CN1101815C 3-aminochromanylsulfonyl (thio) ureas, processes for their prepn. their use, and pharmaceutical prepn. comprising them |
02/19/2003 | CN1101810C Process for prepn. of lercanidipine hydrochloride |
02/18/2003 | US6521758 Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols |
02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
02/18/2003 | US6521650 Amines as pharmaceutical agents |
02/18/2003 | US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
02/18/2003 | US6521619 Bind to the interaction-domain of integrin lfa-1 interrupting enothelial cell-leukocyte adhesion |
02/18/2003 | US6521592 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
02/18/2003 | CA2243542C Resolution of threo-methylphenidate |
02/13/2003 | WO2003011858A1 Substituted isoindoles and e use thereof |
02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
02/13/2003 | WO2003011295A1 Fexofenadine polymorph |
02/13/2003 | WO2002076988A3 Tert. alkylphenoxy substituted polycyclic compounds |
02/13/2003 | US20030032835 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)-benzamide (FLECAINIDE) |
02/13/2003 | US20030032810 Antagonists of natural killer cell-3 receptors |
02/13/2003 | US20030032806 Performed at lower temperature |
02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
02/13/2003 | US20030032654 Useful for the treatment or prevention of asthma and other allergic diseases. |
02/13/2003 | CA2455772A1 Substituted isoindoles and their use |
02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
02/12/2003 | EP1283201A1 Process for the preparation of 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidyl-methyl)-benzamide (flecanide) |
02/12/2003 | EP1283200A2 Optically pure paroxetine precursors |
02/12/2003 | EP1282630A1 Hydroxylamine esters as polymerization initiators |
02/12/2003 | EP1282616A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
02/12/2003 | EP0976733B1 Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof |
02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
02/11/2003 | US6518314 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions |
02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
02/11/2003 | US6518286 Compounds |
02/11/2003 | US6518284 4-substituted piperidines |
02/11/2003 | US6518282 4-Arylpiperidine derivatives for the treatment of pruritus |
02/11/2003 | US6518272 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer |
02/11/2003 | CA2250391C Butadiene derivatives and process for their preparation |